clinical diagnostics and risk analyses could be vastly improved through AI analysis of the exposome along with patient-specific
genomics,
the GIT microbiome analysis, blood analysis of
transcriptome,
proteome, etc, but this requires massive amounts of individualised data and clinical outcomes to train such AI models